Similar to what we observed in the early stage samples, CA125 and HE4 levels were elevated in the late stage ovarian cancer samples, while ITGAV and SEZ6L levels were higher in the healthy control samples. This evidence concerns the gene WFDC2 and ovarian carcinoma.